Robert S Epstein insider trades: Veracyte (VCYT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
49 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | VCYT | ↓ Sell | 10,000 | $44.01 | $440K | Direct | May 22, 2026 (2d) |
| Oct 1, 2025 | VCYT | ↓ Sell | 21,473 | $35.08 | $753K | Direct | Oct 3, 2025 (2d) |
| Nov 12, 2024 | VCYT | ↓ Sell | 15,000 | $38.32 | $575K | Direct | Nov 14, 2024 (2d) |
| Jul 13, 2020 | VCYT | ↓ Sell | 10,000 | $29.73 | $297K | Direct | Jul 14, 2020 (1d) |
| May 1, 2019 | ILMN | ↓ Sell10b5-1 | 5,000 | $310.44 | $1.6M | Direct | May 3, 2019 (2d) |
| Apr 1, 2019 | ILMN | ↓ Sell10b5-1 | 1,000 | $314.45 | $314K | Direct | Apr 3, 2019 (2d) |
| Mar 1, 2019 | ILMN | ↓ Sell10b5-1 | 1,000 | $313.93 | $314K | Direct | Mar 5, 2019 (4d) |
| Feb 1, 2019 | ILMN | ↓ Sell10b5-1 | 1,000 | $280.11 | $280K | Direct | Feb 5, 2019 (4d) |
| Jan 2, 2019 | ILMN | ↓ Sell10b5-1 | 1,000 | $294.71 | $295K | Direct | Jan 4, 2019 (2d) |
| Dec 3, 2018 | ILMN | ↓ Sell10b5-1 | 1,345 | $343.57 | $462K | Direct | Dec 4, 2018 (1d) |
| Nov 1, 2018 | ILMN | ↓ Sell10b5-1 | 1,346 | $311.86 | $420K | Direct | Nov 2, 2018 (1d) |
| Oct 1, 2018 | ILMN | ↓ Sell10b5-1 | 1,346 | $369.15 | $497K | Direct | Oct 3, 2018 (2d) |
| Sep 7, 2018 | ILMN | ↓ Sell10b5-1 | 1,346 | $345.14 | $465K | Direct | Sep 11, 2018 (4d) |
| Jul 23, 2018 | ILMN | ↓ Sell10b5-1 | 500 | $311.15 | $156K | Direct | Jul 24, 2018 (1d) |
| Jun 21, 2018 | ILMN | ↓ Sell10b5-1 | 500 | $288.45 | $144K | Direct | Jun 22, 2018 (1d) |
| May 21, 2018 | ILMN | ↓ Sell10b5-1 | 500 | $271.00 | $136K | Direct | May 22, 2018 (1d) |
| Feb 28, 2018 | ILMN | ↓ Sell10b5-1 | 250 | $231.25 | $58K | Direct | Mar 2, 2018 (2d) |
| Jan 29, 2018 | ILMN | ↓ Sell10b5-1 | 1,250 | $244.18 | $305K | Direct | Jan 30, 2018 (1d) |
| Dec 29, 2017 | ILMN | ↓ Sell10b5-1 | 1,250 | $217.38 | $272K | Direct | Jan 2, 2018 (4d) |
| Dec 1, 2017 | ILMN | ↓ Sell10b5-1 | 1,250 | $226.55 | $283K | Direct | Dec 5, 2017 (4d) |
| Sep 20, 2016 | ILMN | ↓ Sell10b5-1 | 300 | $174.29 | $52K | Direct | Sep 21, 2016 (1d) |
| Aug 22, 2016 | ILMN | ↓ Sell10b5-1 | 300 | $170.27 | $51K | Direct | Aug 24, 2016 (2d) |
| Aug 22, 2016 | ILMN | ↓ Sell10b5-1 | 300 | $170.27 | $51K | Direct | Aug 23, 2016 (1d) |
| Jul 20, 2016 | ILMN | ↓ Sell10b5-1 | 1,200 | $150.00 | $180K | Direct | Jul 20, 2016 (0d) |
| Mar 21, 2016 | ILMN | ↓ Sell10b5-1 | 300 | $154.25 | $46K | Direct | Mar 23, 2016 (2d) |
| Nov 27, 2015 | ILMN | ↓ Sell10b5-1 | 1,000 | $185.56 | $186K | Direct | Nov 30, 2015 (3d) |
| Aug 10, 2015 | ILMN | ↓ Sell10b5-1 | 2,000 | $212.09 | $424K | Direct | Aug 12, 2015 (2d) |
| Jul 10, 2015 | ILMN | ↓ Sell10b5-1 | 2,000 | $219.81 | $440K | Direct | Jul 14, 2015 (4d) |
| Jun 10, 2015 | ILMN | ↓ Sell10b5-1 | 2,000 | $214.24 | $428K | Direct | Jun 11, 2015 (1d) |
| May 11, 2015 | ILMN | ↓ Sell10b5-1 | 2,000 | $196.49 | $393K | Direct | May 12, 2015 (1d) |
| Apr 10, 2015 | ILMN | ↓ Sell10b5-1 | 2,000 | $186.99 | $374K | Direct | Apr 13, 2015 (3d) |
| Mar 10, 2015 | ILMN | ↓ Sell10b5-1 | 3,000 | $191.75 | $575K | Direct | Mar 11, 2015 (1d) |
| Mar 2, 2011 | MHS | ↓ Sell10b5-1 | 35,312 | $63.00 | $2.2M | Direct | Mar 3, 2011 (1d) |
| Mar 1, 2010 | MHS | ↓ Sell10b5-1 | 51,440 | $64.00 | $3.3M | Direct | Mar 2, 2010 (1d) |
| Nov 6, 2009 | MHS | ↓ Sell10b5-1 | 30,000 | $59.48 | $1.8M | Direct | Nov 9, 2009 (3d) |
| Aug 3, 2009 | MHS | ↓ Sell10b5-1 | 37,766 | $52.15 | $2.0M | Direct | Aug 5, 2009 (2d) |
| Aug 8, 2008 | MHS | ↓ Sell10b5-1 | 19,752 | $49.00 | $968K | Direct | Aug 12, 2008 (4d) |
| Aug 7, 2007 | MHS | ↓ Sell | 25,000 | $84.00 | $2.1M | Direct | Aug 7, 2007 (0d) |
| Mar 5, 2007 | MHS | ↓ Sell | 10,400 | $67.31 | $700K | Direct | Mar 6, 2007 (1d) |
| Feb 21, 2007 | MHS | ↓ Sell | 32,900 | $65.68 | $2.2M | Direct | Feb 23, 2007 (2d) |
| Mar 15, 2006 | MHS | ↓ Sell10b5-1 | 10,250 | $58.88 | $604K | Direct | Mar 16, 2006 (1d) |
| Mar 1, 2006 | MHS | ↓ Sell10b5-1 | 64,074 | $59.25 | $3.8M | Direct | Mar 2, 2006 (1d) |
| Feb 27, 2006 | MHS | ↓ Sell10b5-1 | 7,550 | $55.65 | $420K | Direct | Mar 1, 2006 (2d) |
| Dec 15, 2005 | MHS | ↓ Sell | 64,564 | $56.26 | $3.6M | Direct | Dec 19, 2005 (4d) |
| Nov 4, 2005 | MHS | ↓ Sell10b5-1 | 5,528 | $49.20 | $272K | Direct | Nov 8, 2005 (4d) |
| Sep 15, 2005 | MHS | ↓ Sell | 64,920 | $54.25 | $3.5M | Direct | Sep 16, 2005 (1d) |
| Aug 31, 2005 | MHS | ↓ Sell | 7,550 | $48.82 | $369K | Direct | Sep 2, 2005 (2d) |
| Jun 1, 2005 | MHS | ↓ Sell | 5,529 | $50.71 | $280K | Direct | Jun 2, 2005 (1d) |
| May 4, 2005 | MHS | ↓ Sell | 138,939 | $51.25 | $7.1M | Direct | May 6, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VCYT insiders
Open-market trades in the last 12 months
About Robert S Epstein's insider trades
Robert S Epstein is a director at Veracyte (VCYT). Since May 4, 2005, Robert has reported no open-market purchases and 49 sales worth $46.4M on SEC Form 4. In the last 12 months: 1 sale ($440K).
37 sales (53% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (49 filings), option exercises (33 filings), shares withheld for taxes (16 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VCYT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.